Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-02 Sale |
2025-01-03 5:00 pm |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO |
8,510 | $0.5619 | $4,782 | 157,068 (Direct) |
View |
| 2024-09-05 Sale |
2024-09-05 7:48 pm |
Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL |
2,525 | $0.566 | $1,429 | 51,927 (Direct) |
View |
| 2024-01-05 Sale(A) |
2024-02-16 4:37 pm |
Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL |
2,412 | $2.91 | $7,019 | 34,452 (Direct) |
View |
| 2024-01-05 Sale |
2024-01-08 4:38 pm |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel |
2,412 | $2.91 | $7,019 | 34,452 (Direct) |
View |
| 2022-06-23 Sale |
2022-06-24 7:55 pm |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel |
2,614 | $2.69 | $7,032 | 19,097 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-03 Option Award |
2025-03-04 4:28 pm |
N/A 2035-03-02 |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO |
143,158 | $0 | 143,158 (Direct) |
View |
| 2024-12-31 Exercise |
2025-01-03 5:00 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO |
36,667 | $0 | 157,068 (Direct) |
View |
| 2024-11-18 Option Award |
2025-01-03 5:00 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO |
3,651 | $0.55 | 157,068 (Direct) |
View |
| 2024-10-01 Option Award |
2024-10-03 7:08 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO |
220,000 | $0 | 220,000 (Direct) |
View |
| 2024-09-03 Option Award |
2024-09-05 7:48 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL |
10,000 | $0 | 51,927 (Direct) |
View |
| 2024-05-20 Option Award |
2024-09-05 7:48 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL |
10,000 | $1.34 | 51,927 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 5:01 pm |
N/A 2034-02-13 |
Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL |
220,000 | $0 | 220,000 (Direct) |
View |
| 2024-01-04 Option Award(A) |
2024-02-16 4:37 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL |
10,000 | $0 | 34,452 (Direct) |
View |
| 2023-05-18 Option Award(A) |
2024-02-16 4:37 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL |
7,767 | $2.41 | 34,452 (Direct) |
View |
| 2024-01-04 Option Award |
2024-01-08 4:38 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel |
10,000 | $0 | 34,452 (Direct) |
View |
| 2023-05-18 Option Award |
2024-01-08 4:38 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel |
7,767 | $2.41 | 34,452 (Direct) |
View |
| 2023-01-19 Option Award |
2023-01-23 5:55 pm |
N/A 2033-01-18 |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel |
150,000 | $0 | 150,000 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 7:55 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel |
10,000 | $0 | 19,097 (Direct) |
View |
| 2022-05-18 Option Award |
2022-06-24 7:55 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel |
3,396 | $7.06 | 19,097 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-20 5:27 pm |
N/A 2032-01-17 |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel |
150,000 | $0 | 150,000 (Direct) |
View |
| 2021-11-03 Option Award |
2021-11-05 5:03 pm |
N/A 2031-11-02 |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel |
150,000 | $0 | 150,000 (Direct) |
View |
Ownership |
2021-06-01 6:32 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Worthington Mark General Counsel |
0 | $0 | 8,315 (Direct) |
View |